NEU neuren pharmaceuticals limited

Ann: Phase 2 trial shows significant improvements in Angelman, page-44

  1. 8,662 Posts.
    lightbulb Created with Sketch. 2615
    Reasonable value now.

    Angelman is on track, would have been a green day without the downgrade.

    Think brokers might upgrade off the back off this. Dangerous to be short now in my view.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.11
Change
-0.090(0.63%)
Mkt cap ! $1.750B
Open High Low Value Volume
$14.23 $14.71 $14.01 $6.213M 438.0K

Buyers (Bids)

No. Vol. Price($)
1 7700 $14.09
 

Sellers (Offers)

Price($) Vol. No.
$14.16 3278 1
View Market Depth
Last trade - 16.16pm 30/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.